SEVERANCE AGREEMENTSeverance Agreement • February 17th, 2016 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
THIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into effective on the 27th day of July 2015 (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and Bruce J. Seeley (the “Executive”).
CTI BioPharma Corp.Cti Biopharma Corp • February 17th, 2016 • Pharmaceutical preparations
Reference is made to the performance-based stock award (the “Award”) granted to you by CTI BioPharma Corp. (the “Company”), effective as of January 3, 2012 and as subsequently amended, and evidenced by the Equity/Long-Term Incentive Award Agreement, as amended, between you and the Company (the “Award Agreement”). This letter amendment (this “Amendment”) sets forth our agreement to amend the Award Agreement on the terms set forth herein. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Award Agreement.
July 27, 2015 Bruce Seeley CTI BioPharma Corp.Letter Agreement • February 17th, 2016 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
AMENDMENT NO. 3 to EMPLOYMENT AGREEMENTEmployment Agreement • February 17th, 2016 • Cti Biopharma Corp • Pharmaceutical preparations
THIS AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT (this “Amendment”) is dated as of December 23, 2015, by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and James A. Bianco (the “Executive”).
